長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【2160】ジーエヌアイグループ

【2160】ジーエヌアイグループ
バイオ創薬ベンチャー。
類似企業：
【業界1位】 小野薬品工業
【売上同水準】 ペプチドリーム ネクセラファーマ


東証グロース
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2024.12 2024/11/14 Q3予 39,566 → 0.0% 0.0% 16,286 → 0.0% 0.0% 15,552 → 0.0% 0.0% 7,058 → 0.0% 0.0%
2024.12 2024/08/14 Q2予 39,566 → 0.0% 0.0% 16,286 → 0.0% 0.0% 15,552 → 0.0% 0.0% 7,058 → 0.0% 0.0%
2024.12 2024/05/15 Q1予 39,566 → 0.0% 0.0% 16,286 → 0.0% 0.0% 15,552 → 0.0% 0.0% 7,058 → 0.0% 0.0%
2024.12 2024/02/14 当初予 39,566 - - - 16,286 - - - 15,552 - - - 7,058 - - -
2023.12 2024/02/14 実 26,010 ↓ -1.1% +36.9% 13,108 ↓ -16.7% +1148.4% 12,612 ↓ -15.2% +25124.0% 8,094 ↓ -9.8% +547.5%
2023.12 2023/12/06 修正予 26,300 ↑ +0.1% +38.4% 15,744 ↑ +116.3% +1399.4% 14,865 ↑ +131.2% +29630.0% 8,971 ↑ +347.4% +617.7%
2023.12 2023/11/14 Q3予 26,267 → 0.0% +38.2% 7,280 → 0.0% +593.3% 6,430 → 0.0% +12760.0% 2,005 → 0.0% +60.4%
2023.12 2023/11/06 修正予 26,267 ↑ +3.9% +38.2% 7,280 ↑ +21.5% +593.3% 6,430 ↑ +55.2% +12760.0% 2,005 ↑ +17.7% +60.4%
2023.12 2023/08/14 Q2予 25,273 → 0.0% +33.0% 5,991 → 0.0% +470.6% 4,143 → 0.0% +8186.0% 1,703 → 0.0% +36.2%
2023.12 2023/08/03 修正予 25,273 ↑ +33.0% +33.0% 5,991 ↑ +470.6% +470.6% 4,143 ↑ +8186.0% +8186.0% 1,703 ↑ +36.2% +36.2%
2023.12 2023/05/15 Q1予 19,000 → 0.0% 0.0% 1,050 → 0.0% 0.0% 50 → 0.0% 0.0% 1,250 → 0.0% 0.0%
2023.12 2023/02/15 当初予 19,000 - - - 1,050 - - - 50 - - - 1,250 - - -
2022.12 2023/02/15 実 17,418 ↓ -3.4% +6.6% 1,377 ↓ -32.8% -24.1% 767 ↓ -36.8% -22.4% 388 ↓ -68.1% -59.6%
2022.12 2022/11/14 Q3予 18,023 ↑ +10.3% +10.3% 2,050 ↑ +12.9% +12.9% 1,214 ↑ +22.9% +22.9% 1,217 ↑ +26.6% +26.6%
2022.12 2022/08/15 Q2予 16,334 → 0.0% 0.0% 1,815 → 0.0% 0.0% 988 → 0.0% 0.0% 961 → 0.0% 0.0%
2022.12 2022/05/16 Q1予 16,334 → 0.0% 0.0% 1,815 → 0.0% 0.0% 988 → 0.0% 0.0% 961 → 0.0% 0.0%
2022.12 2022/02/14 当初予 16,334 - - - 1,815 - - - 988 - - - 961 - - -
2021.12 2022/02/14 実 12,690 ↓ -0.5% +7.5% 1,624 ↓ -11.2% +33.1% 1,107 ↓ -11.1% -6.2% 1,066 ↓ -13.7% +37.0%
2021.12 2021/11/15 Q3予 12,753 → 0.0% +8.0% 1,828 → 0.0% +49.8% 1,245 → 0.0% +5.5% 1,235 → 0.0% +58.7%
2021.12 2021/08/13 Q2予 12,753 → 0.0% +8.0% 1,828 → 0.0% +49.8% 1,245 → 0.0% +5.5% 1,235 → 0.0% +58.7%
2021.12 2021/08/11 修正予 12,753 ↑ +8.0% +8.0% 1,828 ↑ +49.8% +49.8% 1,245 ↑ +5.5% +5.5% 1,235 ↑ +58.7% +58.7%
2021.12 2021/05/17 Q1予 11,803 → 0.0% 0.0% 1,220 → 0.0% 0.0% 1,180 → 0.0% 0.0% 778 → 0.0% 0.0%
2021.12 2021/02/12 当初予 11,803 - - - 1,220 - - - 1,180 - - - 778 - - -
2020.12 2021/02/12 実 9,773 ↑ +1.0% +1.0% 1,869 ↑ +23.3% +23.3% 1,805 ↑ +23.4% +23.4% 1,258 ↑ +136.0% +136.0%
2020.12 2020/11/13 Q3予 9,672 → 0.0% 0.0% 1,516 → 0.0% 0.0% 1,463 → 0.0% 0.0% 533 → 0.0% 0.0%
2020.12 2020/08/14 Q2予 9,672 → 0.0% 0.0% 1,516 → 0.0% 0.0% 1,463 → 0.0% 0.0% 533 → 0.0% 0.0%
2020.12 2020/05/15 Q1予 9,672 → 0.0% 0.0% 1,516 → 0.0% 0.0% 1,463 → 0.0% 0.0% 533 → 0.0% 0.0%
2020.12 2020/02/14 当初予 9,672 - - - 1,516 - - - 1,463 - - - 533 - - -
2019.12 2020/02/14 実 7,446 ↑ +1.2% +4.6% 1,302 ↓ -4.5% +72.0% 1,197 ↓ -2.2% +61.3% 181 ↓ -52.4% +81.0%
2019.12 2019/11/29 修正予 7,356 ↑ +0.1% +3.3% 1,364 ↑ +16.8% +80.2% 1,224 ↑ +12.7% +65.0% 380 ↑ +51.4% +280.0%
2019.12 2019/11/14 Q3予 7,348 → 0.0% +3.2% 1,168 → 0.0% +54.3% 1,086 → 0.0% +46.4% 251 → 0.0% +151.0%
2019.12 2019/09/06 修正予 7,348 ↑ +3.2% +3.2% 1,168 ↑ +54.3% +54.3% 1,086 ↑ +46.4% +46.4% 251 ↑ +151.0% +151.0%
2019.12 2019/08/14 Q2予 7,119 → 0.0% 0.0% 757 → 0.0% 0.0% 742 → 0.0% 0.0% 100 → 0.0% 0.0%
2019.12 2019/05/15 Q1予 7,119 → 0.0% 0.0% 757 → 0.0% 0.0% 742 → 0.0% 0.0% 100 → 0.0% 0.0%
2019.12 2019/02/14 当初予 7,119 - - - 757 - - - 742 - - - 100 - - -
2018.12 2019/02/14 実 5,018 → 0.0% +1.2% 568 ↑ +6.6% -13.8% 364 ↑ +10.6% -44.1% -200 ↑ +8.7% -
2018.12 2019/02/13 修正予 5,018 ↑ +1.2% +1.2% 533 ↓ -19.1% -19.1% 329 ↓ -49.5% -49.5% -219 ↓ - -
2018.12 2018/11/13 Q3予 4,960 → 0.0% 0.0% 659 → 0.0% 0.0% 651 → 0.0% 0.0% 0 → - -
2018.12 2018/08/14 Q2予 4,960 → 0.0% 0.0% 659 → 0.0% 0.0% 651 → 0.0% 0.0% 0 → - -
2018.12 2018/05/11 Q1予 4,960 → 0.0% 0.0% 659 → 0.0% 0.0% 651 → 0.0% 0.0% 0 → - -
2018.12 2018/02/13 当初予 4,960 - - - 659 - - - 651 - - - 0 - - -
2017.12 2018/02/13 実 2,648 ↓ -8.9% +22.3% 154 ↓ -33.3% +390.6% 137 ↓ -48.5% +821.1% -175 ↓ -177.8% +33.5%
2017.12 2017/11/10 Q3予 2,907 → 0.0% +34.2% 231 → 0.0% +535.8% 266 → 0.0% +1500.0% -63 → 0.0% +76.0%
2017.12 2017/08/10 Q2予 2,907 → 0.0% +34.2% 231 → 0.0% +535.8% 266 → 0.0% +1500.0% -63 → 0.0% +76.0%
2017.12 2017/05/15 Q1予 2,907 → 0.0% +34.2% 231 → 0.0% +535.8% 266 → 0.0% +1500.0% -63 → 0.0% +76.0%
2017.12 2017/04/18 修正予 2,907 ↑ +34.2% +34.2% 231 ↑ +535.8% +535.8% 266 ↑ +1500.0% +1500.0% -63 ↑ +76.0% +76.0%
2017.12 2017/02/15 当初予 2,166 - - - -53 - - - -19 - - - -263 - - -
2016.12 2017/02/15 実 1,306 → 0.0% -14.4% -276 → 0.0% +32.7% -385 → 0.0% +15.4% -513 → 0.0% -2.8%
2016.12 2017/02/14 修正予 1,306 ↓ -14.4% -14.4% -276 ↑ +32.7% +32.7% -385 ↑ +15.4% +15.4% -513 ↓ -2.8% -2.8%
2016.12 2016/08/10 Q2予 1,525 → 0.0% 0.0% -410 → 0.0% 0.0% -455 → 0.0% 0.0% -499 → 0.0% 0.0%
2016.12 2016/05/12 Q1予 1,525 → 0.0% 0.0% -410 → 0.0% 0.0% -455 → 0.0% 0.0% -499 → 0.0% 0.0%
2016.12 2016/02/15 当初予 1,525 - - - -410 - - - -455 - - - -499 - - -
2015.12 2016/02/15 実 1,016 ↓ -2.2% +17.6% -633 ↓ -21.7% +0.9% -669 ↓ -14.6% -16.3% -623 ↓ -7.2% -11.6%
2015.12 2015/11/12 Q3予 1,039 ↑ +20.3% +20.3% -520 ↑ +18.6% +18.6% -584 ↓ -1.6% -1.6% -581 ↓ -4.1% -4.1%
2015.12 2015/08/12 Q2予 864 → 0.0% 0.0% -639 → 0.0% 0.0% -575 → 0.0% 0.0% -558 → 0.0% 0.0%
2015.12 2015/05/13 Q1予 864 → 0.0% 0.0% -639 → 0.0% 0.0% -575 → 0.0% 0.0% -558 → 0.0% 0.0%
2015.12 2015/02/13 当初予 864 - - - -639 - - - -575 - - - -558 - - -
2014.12 2015/02/13 実 474 - - - -550 - - - -440 - - - -327 - - -
2013.12 2014/02/14 実 183 - - - -785 - - - -781 - - - -685 - - -
シェア ツイート
ページトップへ戻る